Thus, novel tools to guide targeted treatment in the early phase of ICU or CCU admission are needed to improve outcomes, such as machine learning for hypoglycemia prediction and close loop insulin delivery systems [60,61]. This evidence concerns the gene INS and Hypoglycemia.